• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Thia fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Thia fatty acids

Introduction to 4-(ethylsulfanyl)-2-hydroxybutanoic Acid (CAS No. 15592-44-6)

4-(ethylsulfanyl)-2-hydroxybutanoic acid, with the chemical formula C₆H₁₁NO₂S, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This organic compound, identified by its CAS number CAS No. 15592-44-6, has garnered attention due to its unique structural properties and potential applications in drug development and biochemical research.

The molecular structure of 4-(ethylsulfanyl)-2-hydroxybutanoic acid features a hydroxybutanoic acid backbone with an ethylsulfanyl group attached to the fourth carbon atom. This configuration imparts distinctive chemical reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active molecules. The presence of both hydroxyl and sulfanyl functional groups enhances its versatility in forming hydrogen bonds and participating in various biochemical interactions.

In recent years, 4-(ethylsulfanyl)-2-hydroxybutanoic acid has been explored for its potential role in the development of novel therapeutic agents. Its structural motif is reminiscent of several known bioactive compounds, suggesting that it may serve as a precursor or analog in drug design. Specifically, researchers have been interested in its ability to modulate enzyme activity and interact with biological targets, which could lead to applications in treating inflammatory diseases, metabolic disorders, and other conditions.

One of the most compelling aspects of 4-(ethylsulfanyl)-2-hydroxybutanoic acid is its capacity to act as a chiral building block. The ethylsulfanyl group introduces steric hindrance and electronic effects that can be fine-tuned to influence the binding affinity and selectivity of potential drug candidates. This property has made it a subject of interest in the field of asymmetric synthesis, where the goal is to produce enantiomerically pure compounds with enhanced pharmacological profiles.

The hydroxyl group in the molecule also plays a crucial role in its reactivity. It can participate in esterification reactions, forming esters that are commonly used in drug formulations to improve solubility and stability. Additionally, the hydroxyl group can engage in hydrogen bonding interactions, which are essential for the binding of small molecules to biological targets such as proteins and nucleic acids.

Recent studies have begun to uncover the pharmacological potential of derivatives of 4-(ethylsulfanyl)-2-hydroxybutanoic acid. For instance, researchers have synthesized several analogs and evaluated their effects on enzymes involved in metabolic pathways. These studies have revealed that certain derivatives exhibit inhibitory activity against key enzymes implicated in inflammation and pain signaling. This finding opens up new avenues for developing drugs that target these pathways more selectively and effectively.

The synthesis of 4-(ethylsulfanyl)-2-hydroxybutanoic acid itself has also been optimized for scalability and efficiency. Advances in synthetic methodologies have enabled the production of this compound in multi-kilogram quantities, making it more accessible for industrial applications. Furthermore, green chemistry principles have been applied to develop more environmentally friendly synthetic routes, reducing waste generation and minimizing the use of hazardous reagents.

In conclusion, 4-(ethylsulfanyl)-2-hydroxybutanoic acid (CAS No. 15592-44-6) represents a promising compound with diverse applications in pharmaceutical chemistry and biochemistry. Its unique structural features make it a valuable building block for drug design, while its reactivity allows for the development of novel therapeutic agents targeting various diseases. As research continues to uncover new insights into its properties and potential uses, this compound is poised to play an increasingly important role in the development of next-generation pharmaceuticals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)